Immunology and Hematopoiesis Division, Department of Oncology, Bloomberg-Kimmel Institute, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Translational Medicine Research Center, Affiliated Jiangning Hospital, and Liver Transplantation Center, First Affiliated Hospital, Nanjing Medical University, Nanjing, China.
Cancer Discov. 2018 Aug;8(8):1026-1043. doi: 10.1158/2159-8290.CD-17-1124. Epub 2018 Jun 15.
Regulatory T cells (Treg) are critical for maintaining self-tolerance and immune homeostasis, but their suppressive function can impede effective antitumor immune responses. FOXP3 is a transcription factor expressed in Tregs that is required for their function. However, the pathways and microenvironmental cues governing FOXP3 expression and Treg function are not completely understood. Herein, we report that YAP, a coactivator of the Hippo pathway, is highly expressed in Tregs and bolsters FOXP3 expression and Treg function and This potentiation stemmed from YAP-dependent upregulation of activin signaling, which amplifies TGFβ/SMAD activation in Tregs. YAP deficiency resulted in dysfunctional Tregs unable to suppress antitumor immunity or promote tumor growth in mice. Chemical YAP antagonism and knockout or blockade of the YAP-regulated activin receptor similarly improved antitumor immunity. Thus, we identify YAP as an unexpected amplifier of a Treg-reinforcing pathway with significant potential as an anticancer immunotherapeutic target. Tregs suppress antitumor immunity, and pathways supporting their function can be novel immunotherapy targets. Here, the selective expression of YAP by Tregs, its importance for their function, and its unexpected enhancement of pro-Treg Activin/SMAD signaling are reported, as are validations of potential cancer-fighting antagonists of YAP and its regulatory targets. .
调节性 T 细胞 (Treg) 对于维持自身耐受和免疫稳态至关重要,但它们的抑制功能可能会阻碍有效的抗肿瘤免疫反应。FOXP3 是 Treg 中表达的转录因子,是其功能所必需的。然而,调控 FOXP3 表达和 Treg 功能的途径和微环境线索尚不完全清楚。在此,我们报告 YAP(Hippo 通路的共激活因子)在 Treg 中高度表达,并增强 FOXP3 表达和 Treg 功能。这种增强源自 YAP 依赖性激活素信号的上调,从而放大了 TGFβ/SMAD 在 Treg 中的激活。YAP 缺陷导致 Treg 功能失调,无法抑制抗肿瘤免疫或促进小鼠肿瘤生长。化学 YAP 拮抗作用以及 YAP 调节的激活素受体的敲除或阻断同样改善了抗肿瘤免疫。因此,我们确定 YAP 是一种增强 Treg 强化途径的意外放大器,具有作为癌症免疫治疗靶点的巨大潜力。Treg 抑制抗肿瘤免疫,支持其功能的途径可能是新的免疫治疗靶点。在此,报告了 Treg 中 YAP 的选择性表达、其对功能的重要性以及其对促 Treg 激活素/SMAD 信号的意外增强,同时还验证了 YAP 及其调节靶点的潜在抗癌拮抗剂。